FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Altamira Therapeutics Ltd. - Common Shares
(NQ:
CYTO
)
0.3001
UNCHANGED
Last Price
Updated: 3:55 PM EST, Dec 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altamira Therapeutics Ltd. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Altamira Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
January 05, 2022
HAMILTON, BERMUDA / ACCESSWIRE / January 5, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection...
From
Altamira Therapeutics
Via
AccessWire
63 Biggest Movers From Yesterday
↗
December 31, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
↗
December 30, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...
Via
Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
↗
December 30, 2021
Gainers BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) rose 33.6% to $3.10 in pre-market trading. BiondVax reported successful closing of $9.8 million follow-on underwritten...
Via
Benzinga
45 Biggest Movers From Yesterday
↗
December 30, 2021
Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME...
Via
Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
↗
December 29, 2021
Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 38.4% to $1.55 after surging 43...
Via
Benzinga
Altamira Therapeutics Provides Update on Bentrio Program
December 29, 2021
- Bentrio™ becoming available through Amazon platform in key German market - Definite Marketing and Distribution Agreement signed for six Asian countries - Preparations for COVID-19 trial advancing -...
From
Altamira Therapeutics
Via
AccessWire
21 Stocks Moving in Wednesday's Pre-Market Session
↗
December 29, 2021
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) rose 95.5% to $2.19 in pre-market trading after surging 43% on Tuesday. Pop Culture Group Co., Ltd (NASDAQ: CPOP) rose 24.2% to $2.87 in...
Via
Benzinga
Altamira Therapeutics Announces Randomization of First Patients in Bentrio Trial in House Dust Mite Allergy
December 16, 2021
HAMILTON, BERMUDA / ACCESSWIRE / December 16, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral...
From
Altamira Therapeutics
Via
AccessWire
Altamira Therapeutics Announces Randomization of First Patient in Bentrio Trial in Seasonal Allergic Rhinitis
December 01, 2021
HAMILTON, BERMUDA / ACCESSWIRE / December 1, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
42 Stocks Moving In Wednesday's Mid-Day Session
↗
November 17, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...
Via
Benzinga
Topics
Initial Public Offering
54 Biggest Movers From Yesterday
↗
November 19, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company...
Via
Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
↗
November 17, 2021
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10...
Via
Benzinga
61 Biggest Movers From Yesterday
↗
November 18, 2021
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...
Via
Benzinga
Topics
Initial Public Offering
Altamira Therapeutics Announces Poster Presentations at AHA Scientific Sessions 2021
November 15, 2021
- Altamira's peptide-based platform for extrahepatic RNA delivery shows promising results in management of abdominal aortic aneurysm in murine disease models - siRNA polyplexes targeting NF-kB suppress...
From
Altamira Therapeutics
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
6 Top Penny Stocks to Watch Today: SNDL, CYTO, BTB, MITQ, PHUN, RLX
↗
November 12, 2021
Today, a range of penny stocks are surging on various news items amid broader market enthusiasm and a risk-on mindset from traders.
Via
InvestorPlace
FTCH Stock: 6 Things to Know About the Deal That Has BofA Feeling Bullish About Farfetch
↗
November 12, 2021
Farfetch (FTCH) stock is catching the eyes of traders on Friday after Bank of America praised a new partnership for the company.
Via
InvestorPlace
CYTO Stock: The Nasal Spray News Blowing Altamira Therapeutics Sky-High Today
↗
November 12, 2021
Altamira Therapeutics (CYTO) stock is rocketing higher on Friday following the release of positive results from a nasal spray test.
Via
InvestorPlace
Altamira Therapeutics Reports Positive In vitro Efficacy Data for Bentrio Nasal Spray in Protecting Against Sars-CoV-2 Delta Variant
November 12, 2021
- Significant reduction of infectious viral titer in human nasal epithelium model with either prophylactic or therapeutic application - Results provide further confirmation for broad applicability in...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Altamira Therapeutics and Wellesta Collaborate for Marketing and Distribution of Bentrio in Six Key Asian Markets
October 25, 2021
HAMILTON, BERMUDA / ACCESSWIRE / October 25, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
44 Biggest Movers From Yesterday
↗
October 15, 2021
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after...
Via
Benzinga
Altamira Therapeutics Receives FDA Acceptance for Bentrio 510(k) Application
October 14, 2021
HAMILTON, BERMUDA / ACCESSWIRE / October 14, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs through RNA...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Altamira Therapeutics to Participate in A.G.P.'s Virtual Biotech and Specialty Pharma Conference
October 06, 2021
HAMILTON, BERMUDA / ACCESSWIRE / October 6, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs through RNA...
From
Altamira Therapeutics
Via
AccessWire
Altamira Submits FDA 510(k) Premarket Notification For Bentrio
↗
September 27, 2021
Altamira Therapeutics Ltd (NASDAQ: CYTO) has submitted a 510(k) premarket notification to the FDA for Bentrio for hay fever. Once cleared, the Company anticipates...
Via
Benzinga
Altamira Therapeutics Provides Update on Bentrio Program
September 27, 2021
- Building Bentrio™ brand and expanding in European markets - 510(k) premarket notification for allergy indication submitted to the U.S. Food and Drug Administration ("FDA") - Distributors signed up...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Altamira Therapeutics to Provide Business Update on Bentrio(TM) Program
September 21, 2021
HAMILTON, BERMUDA / ACCESSWIRE / September 21, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral...
From
Altamira Therapeutics
Via
AccessWire
Altamira Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 09, 2021
HAMILTON, BERMUDA / ACCESSWIRE / September 9, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral...
From
Altamira Therapeutics
Via
AccessWire
Altamira Therapeutics Provides Business Update and Reports First Half 2021 Financial Results
September 08, 2021
- Commercial launch of Bentrio™ nasal spray in first EU markets, with plans to expand to additional European and international markets in the second half of 2021 - Enrollment in Phase 2 trial of AM-125...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Altamira Therapeutics Reports Protective Effects of Bentrio(TM) Nasal Spray Against Influenza A Virus (H1N1)
August 06, 2021
- Significant reduction of viral titer in human nasal epithelium model both in prevention and treatment of influenza infection (p<0.01) - New data demonstrate protective effects in viral infections...
From
Altamira Therapeutics
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Altamira Therapeutics Announces Launch of Website Dedicated to Bentrio(TM) Nasal Spray
August 03, 2021
HAMILTON, BERMUDA / ACCESSWIRE / August 3, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection...
From
Altamira Therapeutics
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
9
Next >
